• HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
“ProActive Investors UK” interviews David Ribeiro
Share
Announcements, News, Video

“ProActive Investors UK” interviews David Ribeiro

May 4, 2016
-
Posted by Webmaster

ProAxsis CEO David Ribeiro was interviewed by ProActive Investors UK. Watch the video on Stock-Tube

May 4, 2016

Related News

Other posts that you should not miss.
Conferences, News

ProAxsis team to attend BIO 2016

June 2, 2016
-
Posted by Webmaster

ProAxsis will be attending the BIO 2016 conference, taking place at the Moscone Convention Center in San Francisco between …

Read More
June 2, 2016
Posted by Webmaster
News, ProteaseTag®

ProAxsis gains further support from Innovate UK

July 24, 2017
-
Posted by Webmaster

Following its previous success in the BioMedical Catalyst competition, ProAxsis Limited (www.proaxsis.com) has now gained further support for …

Read More
July 24, 2017
Posted by Webmaster
News, ProteaseTag®

ProAxsis abstracts at 2017 European Respiratory Society Conference

September 6, 2017
-
Posted by Webmaster

ProAxsis will be presenting further data on its ProteaseTag® technology, at the European Respiratory Society Conference, which takes …

Read More
September 6, 2017
Posted by Webmaster
← PREVIOUS POST
Dr Kelly Moffitt joins ProAxsis team
NEXT POST →
ProAxsis appoints experienced Sales and Marketing Manager
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis supports next generation of scientists
    October 25, 2019

    ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s …

  • ProAxsis welcomes Professor Stephen Smith as new Chairman
    October 25, 2019

    ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman …

  • New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases
    June 3, 2019

    Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • November 18, 2019
    ProAxsis shortlisted for Small Business of the Year Award
  • October 25, 2019
    ProAxsis supports next generation of scientists
  • October 25, 2019
    ProAxsis welcomes Professor Stephen Smith as new Chairman
LATEST TWEETS
Twitter
ProAxsis
Follow Me
@TimFerguson01 https://t.co/00k2mJHY4o
8 days ago
- ProAxsis
Having a great night and delighted to be shortlisted at the #AIBBEawards @eye_business
8 days ago
- ProAxsis
RT @geinarsson: Recommended preprint by Alison Dicker et al. from @ProfJDChalmers group in Dundee on "The Sputum Microbiome Is Associated w…
24 days ago
- ProAxsis
RT @ProfJDChalmers: In summary- lower microbiome diversity means more exacerbations, more lung inflammation and a higher risk of mortality…
25 days ago
- ProAxsis
Copyright © 2016-2018 - ProAxsis - All rights reserved. 
"ProActive Investors UK" interviews David Ribeiro | ProAxsis